WntResearch Crescita futura
Future criteri di controllo 2/6
WntResearch is forecast to grow revenue at 40.7% per annum.
Informazioni chiave
n/a
Tasso di crescita degli utili
n/a
Tasso di crescita dell'EPS
Biotechs crescita degli utili | 48.4% |
Tasso di crescita dei ricavi | 40.7% |
Rendimento futuro del capitale proprio | n/a |
Copertura analitica | Low |
Ultimo aggiornamento | 23 Aug 2024 |
Aggiornamenti recenti sulla crescita futura
Nessun aggiornamento
Recent updates
Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
12/31/2026 | N/A | N/A | N/A | N/A | 1 |
12/31/2025 | 94 | N/A | 77 | 76 | 1 |
12/31/2024 | N/A | N/A | -47 | -49 | 1 |
6/30/2024 | N/A | -41 | -45 | -45 | N/A |
3/31/2024 | N/A | -36 | -38 | -38 | N/A |
12/31/2023 | N/A | -32 | -31 | -31 | N/A |
9/30/2023 | N/A | -31 | -29 | -29 | N/A |
6/30/2023 | N/A | -30 | -29 | -29 | N/A |
3/31/2023 | N/A | -30 | -29 | -29 | N/A |
12/31/2022 | N/A | -31 | -36 | -36 | N/A |
9/30/2022 | N/A | -38 | -37 | -37 | N/A |
6/30/2022 | N/A | -38 | -40 | -40 | N/A |
3/31/2022 | N/A | -39 | -37 | -38 | N/A |
12/31/2021 | N/A | -36 | -31 | -31 | N/A |
9/30/2021 | N/A | -28 | -29 | -29 | N/A |
6/30/2021 | N/A | -25 | -22 | -22 | N/A |
3/31/2021 | N/A | -21 | -22 | -22 | N/A |
12/31/2020 | N/A | -22 | -23 | -22 | N/A |
9/30/2020 | N/A | -23 | -25 | -24 | N/A |
6/30/2020 | N/A | -26 | -27 | -26 | N/A |
3/31/2020 | N/A | -27 | -27 | -25 | N/A |
12/31/2019 | N/A | -25 | -29 | -28 | N/A |
9/30/2019 | N/A | -29 | -29 | -27 | N/A |
6/30/2019 | N/A | -27 | -26 | -25 | N/A |
3/31/2019 | N/A | -25 | -23 | -22 | N/A |
12/31/2018 | N/A | -24 | -18 | -17 | N/A |
9/30/2018 | N/A | -20 | -22 | -21 | N/A |
6/30/2018 | N/A | -22 | -28 | -28 | N/A |
3/31/2018 | N/A | -30 | N/A | -33 | N/A |
12/31/2017 | N/A | -35 | N/A | -35 | N/A |
9/30/2017 | N/A | -34 | N/A | -30 | N/A |
6/30/2017 | N/A | -31 | N/A | -26 | N/A |
3/31/2017 | N/A | -25 | N/A | -23 | N/A |
12/31/2016 | N/A | -20 | N/A | -19 | N/A |
9/30/2016 | -11 | -29 | N/A | -28 | N/A |
6/30/2016 | -5 | -25 | N/A | -24 | N/A |
3/31/2016 | -3 | -20 | N/A | -18 | N/A |
12/31/2015 | N/A | -18 | N/A | -18 | N/A |
9/30/2015 | 14 | -4 | N/A | -3 | N/A |
6/30/2015 | 11 | -4 | N/A | -2 | N/A |
3/31/2015 | 10 | -7 | N/A | -6 | N/A |
12/31/2014 | 8 | -7 | N/A | -8 | N/A |
9/30/2014 | 8 | -6 | N/A | -6 | N/A |
6/30/2014 | 5 | -6 | N/A | -6 | N/A |
3/31/2014 | 4 | -4 | N/A | -6 | N/A |
12/31/2013 | 5 | -4 | N/A | -4 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: Insufficient data to determine if WNT's forecast earnings growth is above the savings rate (1.1%).
Guadagni vs Mercato: Insufficient data to determine if WNT's earnings are forecast to grow faster than the Swedish market
Guadagni ad alta crescita: Insufficient data to determine if WNT's earnings are expected to grow significantly over the next 3 years.
Ricavi vs Mercato: WNT's revenue (40.7% per year) is forecast to grow faster than the Swedish market (0.01% per year).
Ricavi ad alta crescita: WNT's revenue (40.7% per year) is forecast to grow faster than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Insufficient data to determine if WNT's Return on Equity is forecast to be high in 3 years time